MNOSX
Price
$37.21
Change
+$0.11 (+0.30%)
Updated
Oct 8 closing price
Net Assets
353.88M
RERBX
Price
$61.83
Change
+$0.49 (+0.80%)
Updated
Oct 8 closing price
Net Assets
137.54B
Interact to see
Advertisement

MNOSX vs RERBX

Header iconMNOSX vs RERBX Comparison
Open Charts MNOSX vs RERBXBanner chart's image
Manning & Napier Overseas Series S
Price$37.21
Change+$0.11 (+0.30%)
VolumeN/A
Net Assets353.88M
American Funds EUPAC R2
Price$61.83
Change+$0.49 (+0.80%)
VolumeN/A
Net Assets137.54B
MNOSX vs RERBX Comparison Chart in %
View a ticker or compare two or three
VS
MNOSX vs. RERBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOSX is a StrongBuy and RERBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 138B vs. MNOSX (354M). MNOSX pays higher dividends than RERBX: MNOSX (0.88) vs RERBX (0.24). MNOSX was incepted earlier than RERBX: MNOSX (7 years) vs RERBX (23 years). RERBX (1.56) is less costly to investors than MNOSX (1.07). MNOSX is a more actively managed with annual turnover of: 57.00 vs. RERBX (35.00). RERBX has a lower initial minimum investment than MNOSX: RERBX (250) vs MNOSX (2000). RERBX annual gain was more profitable for investors over the last year : 10.25 vs. MNOSX (9.28). MNOSX return over 5 years is better than : 33.33 vs. RERBX (9.41).
MNOSXRERBXMNOSX / RERBX
Total Expense Ratio1.061.5668%
Annual Report Gross Expense Ratio1.071.5669%
Fund Existence7 years23 years-
Gain YTD15.32521.59371%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets354M138B0%
Annual Yield % from dividends0.880.24371%
Returns for 1 year9.2810.2590%
Returns for 3 years58.5247.60123%
Returns for 5 years33.339.41354%
Returns for 10 yearsN/A37.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.503.19
+11.68%
Stoke Therapeutics
AAME2.920.14
+5.22%
Atlantic American Corp
FIVE153.765.26
+3.54%
Five Below
QETAU10.84N/A
N/A
Quetta Acquisition Corp
TONX6.33-0.05
-0.71%
TON Strategy Company